Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts

Company Performance - Hims & Hers Health, Inc. (HIMS) closed at $16.44, with a daily increase of +0.86%, outperforming the S&P 500's gain of 0.28% [1] - Over the past month, HIMS shares have decreased by 2.57%, underperforming the Medical sector's gain of 0.38% and the S&P 500's gain of 2% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.06, reflecting a 250% increase from the same quarter last year [2] - Revenue is forecasted to be $378.82 million, indicating a growth of 67.1% compared to the prior year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $0.22 per share, representing a 300% increase from the previous year [3] - Revenue for the fiscal year is estimated at $1.39 billion, showing a growth of 59.79% from the prior year [3] Analyst Estimates - Changes in analyst estimates for Hims & Hers Health, Inc. are crucial as they reflect the evolving business trends [4] - Positive revisions in estimates indicate analyst optimism regarding the company's business and profitability [4] Zacks Rank and Valuation - Hims & Hers Health, Inc. currently holds a Zacks Rank of 3 (Hold), with the consensus EPS estimate remaining unchanged over the last 30 days [6] - The company is trading at a Forward P/E ratio of 75.76, which is significantly higher than the industry's average Forward P/E of 27.79 [7] Industry Context - The Medical Info Systems industry, part of the Medical sector, holds a Zacks Industry Rank of 67, placing it in the top 27% of over 250 industries [7] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]